205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.76%
Net income growth under 50% of MRVL's 2248.67%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.80%
Negative yoy D&A while MRVL is 19.02%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
56.86%
Some yoy growth while MRVL is negative at -7464.55%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-16.00%
Both cut yoy SBC, with MRVL at -20.36%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
238.74%
Slight usage while MRVL is negative at -70.98%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
89.81%
AR growth well above MRVL's 108.97%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
82.81%
Inventory shrinking or stable vs. MRVL's 210.40%, indicating lean supply management. David Dodd would confirm no demand shortfall.
123.08%
A yoy AP increase while MRVL is negative at -450.95%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
742.31%
Some yoy usage while MRVL is negative at -1487.37%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-384.38%
Both negative yoy, with MRVL at -8100.11%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
47.26%
Some CFO growth while MRVL is negative at -14.76%. John Neff would note a short-term liquidity lead over the competitor.
-45.21%
Both yoy lines negative, with MRVL at -2.86%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
45.21%
Less M&A spending yoy vs. MRVL's 331.65%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
7.44%
Less growth in investment purchases vs. MRVL's 100.00%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
211.18%
We have some liquidation growth while MRVL is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-45.91%
We reduce yoy other investing while MRVL is 68.08%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
54.50%
Lower net investing outflow yoy vs. MRVL's 325.27%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
-7.32%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.